With ongoing trade tensions and new tariffs reshaping global supply chains, biopharma companies are facing increased uncertainty. From securing critical raw materials to maintaining cost-effective manufacturing, the stakes are high. How can companies stay resilient in this evolving landscape?

In a recent interview with Pharmaceutical Executive, Project Farma President, Anshul Mangal, shares insights on the challenges ahead and how companies can adapt. He discusses the immediate and long-term effects of tariffs, strategies for mitigating risk, and the importance of proactive planning.

Read Anshul’s interview for his expert insights on:

• The impact of tariffs on biomanufacturing and supply chains
• Diversification strategies to build resilience
• How public-private partnerships can help mitigating disruptions

Read PharmExec’s full interview in, “Strategizing for an Uncertain Trade War: Q&A with Anshul Mangal.“